Retin-A Micro Related Published Studies
Well-designed clinical trials related to Retin-A Micro (Tretinoin Topical)
Effect of Aloe vera topical gel combined with tretinoin in treatment of mild and
moderate acne vulgaris: a randomized, double-blind, prospective trial. [2014]
Tretinoin cyclodextrin complex (RA/CyD) causes less irritation with an equal
antiwrinkle effect compared with conventional tretinoin: clinical and histologic
studies of photoaged skin. [2012]
A randomized, double-blind, placebo-controlled, pilot study to assess the
efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for
the treatment of acne rosacea over 12 weeks. [2012]
A randomized, double-blind, controlled comparative trial of the anti-aging
properties of non-prescription tri-retinol 1.1% vs. prescription tretinoin
0.025%. [2012]
Cortexolone 17alpha-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0.05% cream. [2011.07]
Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin or ciclosporin A. [2011.04]
Comparison of tretinoin 0.05% cream and 3% alcohol-based salicylic acid preparation in the treatment of acne vulgaris. [2011.03]
Comparison between 1% tretinoin peeling versus 70% glycolic acid peeling in the
treatment of female patients with melasma. [2011]
Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening regimen. [2010.07]
A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen. [2010.03]
A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/ clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgaris. [2010.02]
Alitretinoin for severe chronic hand Eczema: a NICE single technology appraisal. [2010]
Successful retreatment with alitretinoin in patients with relapsed chronic hand
eczema. [2010]
Tolerability of high-dose topical tretinoin: the Veterans Affairs Topical Tretinoin Chemoprevention Trial. [2009.10]
Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial. [2009.08]
Reappraising the phototoxicity of tretinoin: a report of four controlled clinical trials. [2009.06]
Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel. [2009.04]
Association between statin use and risk for keratinocyte carcinoma in the veterans affairs topical tretinoin chemoprevention trial. [2009.01.06]
Improvement of photoaged facial skin in middle-aged Japanese females by topical retinol (vitamin A alcohol): a vehicle-controlled, double-blind study. [2009]
A novel gel formulation of clindamycin phosphate-tretinoin is not associated with acne flaring. [2008.08]
Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. [2008.04]
Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne. [2007.07]
Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial. [2007.06]
Cost-effectiveness of a fixed combination of hydroquinone/tretinoin/fluocinolone cream compared with hydroquinone alone in the treatment of melasma. [2007.02]
Tretinoin microsphere gel 0.1% for photodamaged facial skin: a placebo-controlled trial. [2006.12]
Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne. [2006.11]
Facilitating facial retinization through barrier improvement. [2006.10]
Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies. [2006.09]
Safety and efficacy of Tretin-X compared with Retin-A in patients with mild-to-severe acne vulgaris. [2006.05]
The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes. [2005.11]
Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream. [2005.07]
Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial. [2005]
Well-designed clinical trials possibly related to Retin-A Micro (Tretinoin Topical)
Instrumental analysis of the pattern of improvement and that of recurrence of melasma in Thai females treated with Kligman-Willis triple combination therapy: confirmation by using its two different formulae. [2011.05]
Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study. [2011.03]
Sequential treatment with triple combination cream and intense pulsed light is more efficacious than sequential treatment with an inactive (control) cream and intense pulsed light in patients with moderate to severe melasma. [2011.02]
Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial. [2010.08]
Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream. [2010.06]
Consensus statement on the management of chronic hand eczema. [2009.10]
Effects of a cosmetic 'anti-ageing' product improves photoaged skin [corrected]. [2009.08]
Comparative efficacy and safety results of two topical combination acne regimens. [2009.07]
Comparative evaluation of the efficacy of four topical medications individually or in combination to treat grade I acne vulgaris. [2009.04]
Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. [2008.09.03]
Loss of elastic fibers causes skin wrinkles in sun-damaged human skin. [2008.05]
Reliability of the histopathologic diagnosis of keratinocyte carcinomas. [2007.08]
A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. [2007.03]
Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo. [2006.08]
A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads. [2005.09]
Other research related to Retin-A Micro (Tretinoin Topical)
Superficial dermabrasion versus topical tretinoin on early striae distensae: a
randomized, pilot study. [2014]
Predictors of local adverse effects caused by topical tretinoin cream 0ยท1% in the
Veterans Affairs Topical Tretinoin Chemoprevention trial. [2014]
Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in
combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial
acne vulgaris. [2013]
All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very
long-term follow-up of the North American Intergroup Study I0129. [2013]
Assessing the bioequivalence of topical retinoid products by pharmacodynamic
assay. [2012]
Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical
Tretinoin Chemoprevention) trial. [2012]
Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin
alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study. [2012]
Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell
carcinoma of the skin): a veterans affairs randomized chemoprevention trial. [2012]
Use of topical tretinoin and the development of noncutaneous adverse events: Evidence from a systematic review of the literature. [2011.12]
Clindamycin 1.2% Tretinoin 0.025% Gel versus Clindamycin Gel Treatment in Acne Patients: A Focus on Fitzpatrick Skin Types. [2011.06]
Evidence-based review: fixed-combination therapy and topical retinoids in the treatment of acne. [2011.06]
Everyday clinical experience of alitretinoin in the treatment of severe chronic hand eczema: seven case studies. [2011.03]
An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids. [2011.03]
Clinical effect of tocoretinate on lichen and macular amyloidosis. [2011.02]
Comparative study of 5 % potassium hydroxide solution versus 0.05% tretinoin
cream for Molluscum Contagiosum in children. [2011]
Comparison of micronized tretinoin gel 0.05% and tretinoin gel microsphere 0.1%
in young adolescents with acne: a post hoc analysis of efficacy and tolerability
data. [2011]
The efficacy and safety of arsenic trioxide with or without all-trans retinoic
acid for the treatment of acute promyelocytic leukemia: a meta-analysis. [2011]
Association between non-steroidal anti-inflammatory drugs and keratinocyte
carcinomas of the skin among participants in the Veterans Affairs Topical
Tretinoin Chemoprevention Trial. [2011]
Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin
or ciclosporin A. [2011]
Topical retinoids in the management of photodamaged skin: from theory to evidence-based practical approach. [2010.12]
Changes in skin barrier during treatment with systemic alitretinoin: focus on skin susceptibility and stratum corneum ceramides. [2010.11]
Lack of effects on male fertility from a quadrivalent HPV vaccine in Sprague-Dawley rats. [2010.10]
Comparison of tretinoin 0.05% cream and 3% alcohol-based salicylic acid preparation in the treatment of acne vulgaris. [2010.07.28]
Tretinoin for the treatment of photodamaged skin. [2010.07]
Melasma: treatment with 10% tretinoin peeling mask. [2010.06]
Alitretinoin for the treatment of severe chronic hand eczema. [2010.05]
Cosmeceuticals: the evidence behind the retinoids. [2010.01]
Irritation potential of tretinoin gel microsphere pump versus adapalene plus
benzoyl peroxide gel. [2010]
Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment
of acne vulgaris: morning/morning regimen is as effective and safe as
morning/evening regimen. [2010]
Cosmeceuticals: the evidence behind the retinoids. [2010]
A randomized, controlled comparative study of the wrinkle reduction benefits of a
cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a
prescription 0.02% tretinoin product regimen. [2010]
A randomized, investigator-blinded trial to assess the antimicrobial efficacy of
a benzoyl peroxide 5%/ clindamycin phosphate 1% gel compared with a clindamycin
phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgaris. [2010]
A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% cream. [2009.12]
Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles. [2009.10.20]
Alitretinoin: in severe chronic hand eczema. [2009.08.20]
Beyond tretinoin: cosmeceuticals for aging skin. [2009.07]
Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial. [2009.05]
Detection of HPV-15 in painful subungual tumors of incontinentia pigmenti: successful topical therapy with retinoic acid. [2009.05]
A combined analysis of 2 randomized clinical studies of tretinoin gel 0.05% for the treatment of acne. [2009.03]
Alopecia in congenital hidrotic ectodermal dysplasia responding to treatment with a combination of topical minoxidil and tretinoin. [2009.02]
Topical tretinoin therapy and all-cause mortality. [2009.01]
The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review. [2009]
Phase 4 study to assess tretinoin pump for the treatment of facial acne. [2008.12]
Topical retinoids in acne--an evidence-based overview. [2008.12]
Development of SLNs from natural lipids: application to topical delivery of tretinoin. [2008.11.03]
Cosmeceuticals: focus on topical retinoids in photoaging. [2008.11]
Safety of a novel gel formulation of clindamycin phosphate 1.2%-tretinoin 0.025%: results from a 52-week open-label study. [2008.11]
Talarozole, a selective inhibitor of P450-mediated all-trans retinoic acid for the treatment of psoriasis and acne. [2008.11]
Clindamycin phosphate/tretinoin gel formulation in the treatment of acne vulgaris. [2008.11]
[Alitretinoin: a new treatment option for chronic refractory hand eczema] [2008.09]
Cumulative irritation potential of topical retinoid formulations. [2008.08]
Alitretinoin: a comprehensive review. [2008.03]
Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature. [2008.02]
Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for periorbital skin hyperpigmentation in Asians. [2008.01]
|